Androgenetic alopecia

3 trials MedDRA PT
3 Registered trials
0 Recruiting
3 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
ATC code not specified 2
D Dermatology (ATC D) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 2 Phase I (Other): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

2 trials
  • Cassiopea S.p.A. Commercial
    CLASCOTERONE
    2023-504421-39-00 2 countries 2023 n=629
    Ended
  • Industrial Farmaceutica Cantabria S.A. Commercial
    MINOXIDIL
    2023-503383-17-01 4 countries 2024 n=500
    Ended

Phase I (Other)

1 trial
  • Bioresearch Pharma S.A. Commercial
    IMP not specified
    2025-522468-34-00 1 country n=24
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Bioresearch Pharma S.A. Commercial 1 Phase I (Other) 0
Cassiopea S.p.A. Commercial 1 Phase III 0
Industrial Farmaceutica Cantabria S.A. Commercial 1 Phase III 0
New trials by year
2023
1
2024
1
← All indication landscapes